Close Menu

The Slow Transition

Washington University in St. Louis' Dan Koboldt blogs about their transition from a capillary-based to a massively parallel sequencing platform. They formed a focus group to look at the different programs for aligning and detecting variants in next-gen sequence data and have decided to test five or six of them with data from the work they've done on the 1000 Genomes Project. Those aligners being tested include Maq, Eland, BLAT, and cross_match.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.